Price $15.38 |
Market Cap
488.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.37
|
P/S
18.95
|
Dividend %
-
|
|
P/CF
5.6
|
P/FCF
6.2
|
Op. Cash Flow
81.7K
|
FCF
2.5
|
|
Op. Margin
-94.20%
|
Net Margin
-47.80%
|
ROE
-3.50%
|
ROI
-4.80%
|
|
ROA
-3.40%
|
EPS Growth
-102.50%
|
Current Ratio
81.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AmerisourceBergen Corp. (ABC) | $121.50 | - | 1.40% | 25.97B | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.20 | - | - | 42.6M | Strong Buy |
| Recro Pharma Inc (REPH) | $2.10 | - | - | 114M | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $23.96 | - | - | 1.1B | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $60.33 | - | 3.00% | 146.93B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
